Vicapsys Life Sciences, Inc. (VICP)

USD 7.0

(0.0%)

Net Debt Summary of Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.'s latest annual net debt in 2023 was 344.44 Thousand USD , up 2543.4% from previous year.
Vicapsys Life Sciences, Inc.'s latest quarterly net debt in 2023 Q1 was -4140.00 USD , up 70.63% from previous quarter.
Vicapsys Life Sciences, Inc. reported annual net debt of -14.09 Thousand USD in 2022, up 93.51% from previous year.
Vicapsys Life Sciences, Inc. reported annual net debt of -217.29 Thousand USD in 2021, down -17023.33% from previous year.
Vicapsys Life Sciences, Inc. reported quarterly net debt of 31.83 Thousand USD for 2023 Q2, up 868.84% from previous quarter.
Vicapsys Life Sciences, Inc. reported quarterly net debt of -4140.00 USD for 2023 Q1, up 70.63% from previous quarter.

Annual Net Debt Chart of Vicapsys Life Sciences, Inc. (2023 - 2008)

Historical Annual Net Debt of Vicapsys Life Sciences, Inc. (2023 - 2008)

Year	Net Debt	Net Debt Growth
2023	344.44 Thousand USD	2543.4%
2022	-14.09 Thousand USD	93.51%
2021	-217.29 Thousand USD	-17023.33%
2020	-1269.00 USD	99.52%
2019	-264.16 Thousand USD	-206.0%
2018	-86.33 Thousand USD	84.23%
2017	-547.59 Thousand USD	0.0%
2009	2.62 Million USD	119.94%
2008	1.19 Million USD	0.0%

Year	Net Debt	Net Debt Growth
2023 Q4	344.44 Thousand USD	35.76%
2023 Q2	31.83 Thousand USD	868.84%
2023 Q1	-4140.00 USD	70.63%
2023 Q3	253.72 Thousand USD	697.11%
2022 Q4	-14.09 Thousand USD	46.22%
2022 Q3	-26.21 Thousand USD	-51.6%
2022 Q1	-101.31 Thousand USD	53.37%
2022 Q2	-17.28 Thousand USD	82.94%
2022 FY	-14.09 Thousand USD	93.51%
2021 Q4	-217.29 Thousand USD	-31.26%
2021 FY	-217.29 Thousand USD	-17023.33%
2021 Q3	-165.54 Thousand USD	2.97%
2021 Q2	-170.62 Thousand USD	-460.1%
2021 Q1	-30.46 Thousand USD	-2300.55%
2020 Q3	-1654.00 USD	66.83%
2020 Q4	-1269.00 USD	23.28%
2020 Q2	-4986.00 USD	83.89%
2020 Q1	-30.94 Thousand USD	88.28%
2020 FY	-1269.00 USD	99.52%
2019 Q3	-510.64 Thousand USD	0.0%
2019 FY	-264.16 Thousand USD	-206.0%
2019 Q4	-264.16 Thousand USD	48.27%
2019 Q1	86.33 Thousand USD	200.0%
2018 Q4	-86.33 Thousand USD	0.0%
2018 FY	-86.33 Thousand USD	84.23%
2017 FY	-547.59 Thousand USD	0.0%
2010 Q2	3.68 Million USD	56.03%
2010 Q1	2.36 Million USD	23459371.75%
2009 Q4	-10.08 USD	0.0%
2009 FY	2.62 Million USD	119.94%
2008 FY	1.19 Million USD	0.0%

Peer Net Debt Comparison of Vicapsys Life Sciences, Inc.

Name	Net Debt	Net Debt Difference
America Great Health	1.81 Million USD	81.034%
Gene Biotherapeutics, Inc.	- USD	-Infinity%
Evolutionary Genomics, Inc.	3.16 Million USD	89.123%
Innovation1 Biotech Inc.	179.15 Thousand USD	-92.267%
Point of Care Nano-Technology, Inc.	-498.00 USD	69265.863%